PREMIUM
SONIA MORENO
Madrid
Thursday, February 11, 2021 - 10:44
Share on Facebook
Share on Twitter
Send by email
Treatment.
This is the therapy that 'trains' your own defenses to fight cancer
Hematology.
Long-term survival of CAR-T therapies demonstrated for the first time
CAR-T.
A child with leukemia, cured thanks to a pioneering therapy in public health
CAR-T cell therapy is already an option for patients with acute lymphoblastic leukemia over 25 years of age who relapse, thanks to the work of a team of doctors and researchers from the Hospital Clínic de Barcelona. This treatment, called CAR ARI-0001 , has just received approval from the Spanish Agency for Medicines and Health Products (AEMPS).
It thus becomes the first CAR-T developed entirely in Europe to receive the green light from a regulatory agency.
The
Become Premium and
enjoy 3 months for € 1
Take advantage of this limited time offer and access all web content
I want it
Are you already Premium?
Log in
Cancel whenever you want
Check the terms and conditions of the service
According to the criteria of The Trust Project
Know more